Improved antibiotic-free DNA vaccine vectors utilizing a novel RNA based plasmid selection system

Vaccine

Volumn 27, Issue 46, 2009, Pages 6454-6459

  Luke, Jeremy ^a   Carnes, Aaron E ^a   Hodgson, Clague P ^a   Williams, James A ^a  

^a NATURE TECHNOLOGY CORPORATION   (United States)

Author keywords

Antibiotic free; DNA vaccine; Plasmid

Indexed keywords

CHLORAMPHENICOL; COMPLEMENTARY RNA; DNA VACCINE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; KANAMYCIN; NTC7382 41H HA DNA VACCINE VECTOR; NTC8382 41H HA DNA VACCINE VECTOR; PDNAVACCULTRA ENHANCED GREEN FLUORESCENT PROTEIN DNA VACCINE VECTOR; PLASMID VECTOR; SUCROSE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIOPHAGE LAMBDA; CELL CULTURE; CONTROLLED STUDY; DNA IMMUNIZATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE; GENE MUTATION; GENETIC TRANSFECTION; IMMUNOGENICITY; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RESTRICTION MAPPING; SACB GENE; SEROCONVERSION; WESTERN BLOTTING;

ANIMALS; ATTACHMENT SITES, MICROBIOLOGICAL; CELL LINE; FEMALE; FERMENTATION; GENETIC VECTORS; HUMANS; MICE; MICE, INBRED BALB C; PLASMIDS; PROMOTER REGIONS, GENETIC; RNA; TRANSFECTION; VACCINES, DNA;

EID: 70350077805     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.06.017     Document Type: Article

References (21)

1. Carnes A.E., and Williams J.A. Plasmid DNA manufacturing technology. Recent Pat Biotechnol 1 (2007) 151-166
2. Glenting J., and Wessels S. Ensuring safety of DNA vaccines. Microbial Cell Factories 4 (2005) 26-30
3. European Medicines Agency. Note for guidance on the quality, preclinical and clinical aspects of gene transfer medicinal products. CPMP/BWP/3088/99; 2001.
4. Soubrier F., Cameron B., Manse B., Somarriba S., Dubertret C., Jaslin G., et al. pCOR: a new design of plasmid vectors for nonviral gene therapy. Gene Ther 6 (1999) 1482-1488
5. Eastman EM, Durland RH. Plasmid for delivery of nucleic acid to cells and method of use. US Patent 6103470; 2003.
6. Cranenburgh R.M., Hanak J.A., Williams S.G., and Sherratt D.J. Escherichia coli strains that allow antibiotic-free plasmid selection and maintenance by repressor titration. Nucleic Acids Res 29 (2001) E26
7. Szpirer C.Y., and Milinkovitch M.C. Separate-component-stabilization system for protein and DNA production without the use of antibiotics. Biotechniques 38 (2005) 775-781
8. Mairhofer J., Pfaffenzeller I., Merz D., and Grabherr R. A novel antibiotic free plasmid selection system: advances in safe and efficient DNA therapy. Biotechnol J 3 (2008) 83-89
9. Grabherr R, Pfaffenzeller I. Host-vector system for antibiotic-free ColE1 plasmid propagation. World Patent Application WO2006029985; 2006.
10. Cranenburgh RM. Plasmid maintenance. World Patent Application WO2005052167; 2005.
11. Haldimann A., and Wanner B.L. Conditional-replication, integration, excision, and retrieval plasmid-host systems for gene structure-function studies of bacteria. J Bacteriol 183 (2001) 6384-6393
12. Carnes AE, Williams JA, Hodgson CP. Improved E. coli plasmid DNA production. World Patent Application WO2009025690; 2009.
13. Williams J.A., Luke J., Johnson L., and Hodgson C. pDNAVACCultra vector family: high throughput intracellular targeting DNA vaccine plasmids. Vaccine 24 (2006) 4671-4676
14. CBER. Guidance for industry: considerations for plasmid DNA vaccines for infectious disease indications, CBER; 2007.
15. Williams JA. Vectors and methods for genetic immunization. World Patent Application WO2008153733; 2008.
16. Lavigueur A., La Branche H., Kornblihtt A.R., and Chabot B. A splicing enhancer in the human fibronectin alternate ED1 exon interacts with SR proteins and stimulates U2 snRNP binding. Genes Develop 7 (1993) 2405
17. Barouch D.H., Yang Z.Y., Kong W.P., Korioth-Schmitz B., Sumida S.M., Truitt D.M., et al. A human T-cell leukemia virus type 1 regulatory element enhances the immunogenicity of human immunodeficiency virus type 1 DNA vaccines in mice and nonhuman primates. J Virol 79 (2005) 8828-8834
18. Jaenecke S., de Lorenzo V., Timmis K.N., and Diaz E. A stringently controlled expression system for analysing lateral gene transfer between bacteria. Molec. Microbiol. 21 (1996) 293-300
19. Reyrat J.M., Pelicic V., Gicquel B., and Rappuoli R. Counterselectable markers: untapped tools for bacterial genetics and pathogenesis. Infection Immun 66 (1998) 4011-4017
20. Carnes A.E., Hodgson C.P., and Williams J.A. Inducible Escherichia coli fermentation for increased plasmid DNA production. Biotechnol Appl Biochem 45 (2006) 155-166
21. Carnes AE, Williams JA. Process for plasmid DNA fermentation. World Patent Application WO2006023546; 2006.